Arrow-right Camera

The Spokesman-Review Newspaper The Spokesman-Review

Tuesday, November 19, 2019  Spokane, Washington  Est. May 19, 1883
Partly Cloudy Night 41° Partly Cloudy


Everything tagged

Sort by:

Stories tagged: mylan

UPDATED: Mon., July 29, 2019

Pfizer, Mylan strengthen ties, create new company

Pfizer, the country’s largest drugmaker, is creating a hybrid new drug company by combining its off-patent branded drug business, Upjohn, with generic pharmaceutical company Mylan. The two companies said Monday …

UPDATED: Thu., Aug. 17, 2017

Mylan’s EpiPen settlement on defrauding Medicaid gets finalized

Mylan’s $465 million settlement of a U.S. case that claimed the drugmaker defrauded taxpayers by misclassifying its allergy-shot EpiPen product as a generic drug was finalized by the Justice Department.

Legislation needed to curb drug-price hikes

Recent legislation in the U.S. Senate and in the Washington Legislature may eventually shine a brighter light on pricing practices.

UPDATED: Thu., Jan. 12, 2017

CVS selling rival, generic version of EpiPen at sixth of its price

CVS is now selling a rival, generic version of Mylan’s EpiPen at about a sixth of its price, just months after the maker of the life-saving allergy treatment was eviscerated …

Mylan releases a half-priced generic version of EpiPen

Months after promised, Mylan launched a half-priced authorized generic of EpiPen, the lifesaving allergy injection that drew political ire for its dramatic price increases.

EpiPen manufacturer will be a no-show at Senate hearing

Senate Judiciary Chairman Charles Grassley says pharmaceutical company Mylan is declining to testify at his committee’s hearing next week on a settlement between the company and the Justice Department over …

Mylan’s EpiPen profits are 60 percent more than it told Congress, report says

Lawmakers were skeptical last week when Mylan chief executive Heather Bresch said that the company made only $100 in profit for a two-pack of EpiPens. During a House hearing, Bresch …

Mylan CEO defends EpiPen cost to angry lawmakers

Outraged Republican and Democratic lawmakers on Wednesday grilled the head of pharmaceutical company Mylan about the significant cost increase of its lifesaving EpiPens and the profits for a company with …

Gary Crooks: U.S. health care not a bargain

The reality is that patients in other countries are charged less for health care services and drugs across the board, because their governments make it so.

Opinion: EpiPen price gouging pales in comparison to Mylan’s treatment of America

Mylan, the giant pharmaceutical company, has gotten tons of grief lately for jacking up the price of its lifesaving EpiPen. What you might not know is that Mylan moved it …

Mylan launching cheaper, generic version of EpiPen

Mylan will start selling a cheaper version of its EpiPen after absorbing waves of criticism over a list price for the emergency allergy treatment that has grown to $608 for …